Next Article in Journal
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5
Next Article in Special Issue
Characterization of Live-Attenuated Powassan Virus Vaccine Candidates Identifies an Efficacious Prime-Boost Strategy for Mitigating Powassan Virus Disease in a Murine Model
Previous Article in Journal
Development, Safety, Issues, and Challenges of the SARS-CoV-2 Vaccine
Previous Article in Special Issue
Recent Developments in Vaccines against Flaviviruses and Alphaviruses
 
 
Review

Article Versions Notes

Vaccines 2023, 11(3), 568; https://doi.org/10.3390/vaccines11030568
Action Date Notes Link
article xml file uploaded 1 March 2023 10:31 CET Original file -
article xml uploaded. 1 March 2023 10:31 CET Update -
article pdf uploaded. 1 March 2023 10:31 CET Version of Record https://www.mdpi.com/2076-393X/11/3/568/pdf-vor
article html file updated 1 March 2023 10:32 CET Original file -
article xml file uploaded 14 March 2023 02:29 CET Update -
article xml uploaded. 14 March 2023 02:29 CET Update https://www.mdpi.com/2076-393X/11/3/568/xml
article pdf uploaded. 14 March 2023 02:29 CET Updated version of record https://www.mdpi.com/2076-393X/11/3/568/pdf
article html file updated 14 March 2023 02:30 CET Update -
article html file updated 19 March 2023 20:08 CET Update https://www.mdpi.com/2076-393X/11/3/568/html
Back to TopTop